bluuebunny/crossref_metadata_2025_split huggingface dataset:
Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials
Authors: Lin Yaowang , Cai Zhigang , Dong Shaohong , Liu Huadong , Pang Xinli , Chen Qiuling , Yuan Jie , Geng Qingshan 
Published: September 2022

Aimed to evaluate and compare the interactive effects of different antiplatelet or anticoagulation strategies in patients with chronic coronary syndromes (CCS) after percutaneous coronary intervention (PCI). Randomized controlled trials comparing different antiplatelet or anticoagulant strategies in patients with CCS after PCI were included. The primary outcomes were major adverse cardiovascular event (MACE), mortality, ischemic and bleeding events. Compared to aspirin alone, addition of prasugrel or ticagrelor to aspirin resulted in lower risk of myocardial infarction (MI) [odds ratio (OR): 0.38 (95% confidence interval 0.38–0.62); 0.810–0.84 (0.69–0.98)] and any stroke [0.56 (0.42–0.75)] at the expense of increased risk of major bleeding [1.79 (1.34–2.39); 2.08–2.38 (1.56–3.28)], whereas, clopidogrel monotherapy reduced the risk of any stroke, major bleeding, and intracranial bleeding. On subgroup analysis, compared with aspirin alone, addition of prasugrel resulted in lower MACE [0.72 (0.60–0.86)], MI [0.48 (0.38–0.62)], and stent thrombosis [0.29 (0.09–0.91)], whereas, addition of rivaroxaban 2.5 mg resulted in lower risk of MACE [0.72 (0.60–0.87)], cardiac death [0.71 (0.52–0.98)] and any stroke [0.65 (0.45–0.95)], but not reduced MI. Both prasugrel and rivaroxaban 2.5 mg increased major bleeding [1.79 (1.34–2.39); 1.72 (1.33–2.22)]. Clopidogrel monotherapy was associated with lower MACE [0.72 (0.58–0.90)], any stroke [0.42 (0.24–0.73)], and major bleeding [0.62 (0.40–0.96)]. Adding prasugrel or ticagrelor led to a reduced incidence of MI and prasugrel was also found to reduce the risk of MACE and stent thrombosis in CCS patients with low risk of bleeding after PCI. Clopidogrel monotherapy has advantage in reducing MACE, stroke, and major bleeding events in CCS patients at high risk of bleeding after PCI.Systematic Review Registration:https://clinicaltrials.gov/, PROSPERO Identifier: CRD 42021291050.
Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs
Authors: Filimonova Marina , Shevchenko Ljudmila , Makarchuk Victoria , Saburova Alina , Shegay Petr , Kaprin Andrey , Ivanov Sergey , Filimonov Alexander 
Published: September 2022

The development of new effective and safe vasopressors is one of the ways to increase the effectiveness of the treatment of hypotensive disorders, the severe forms of which remain a common cause of death in all countries of the world. Previously, we synthesized the original compound T1059, a selective inhibitor of eNOS/iNOS which has a pronounced vasoconstrictive effect. Here we show its vasopressor activity in models of the early stage of acute hemorrhagic shock in rats and dogs, as part of preclinical studies. The results indicate NOS inhibitor T1059 as a potent long-acting vasopressor. Its single parenteral administration in sufficiently safe doses (1/50–1/9 LD10), caused in rats and dogs a rapid increase in vascular tone, accompanied by a prolonged hypertensive effect (within 90–120 min in rats, and within 115 min in dogs). The repeated administration of T1059 at low doses (1/3 of the first dose) made it possible to considerably (by at least 60 min) prolong a significant vasopressor effect. In all schemes, T1059 administration considerably inhibited the development of threatening cardiorespiratory disorders and significantly (p = 0.0026–0.0098) increased the short-term survival of experimental animals, formally extending the duration of the “golden hour” by 2 times. These data indicate that NOS inhibitors and, in particular, compound T1059, are able to create new opportunities in the treatment of hypotensive disorders, including the provision of assistance at the prehospital stage of treatment of such pathologies.
Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseases
Authors: Hsiao Ching-Chung , Yeh Jih-Kai , Li Yan-Rong , Sun Wei-Chiao , Fan Pei-Yi , Yen Chieh-Li , Chen Jung-Sheng , Lin Chihung , Chen Kuan-Hsing 
Published: September 2022

Background: Statins are commonly used for cardiovascular disease (CVD) prevention. Observational studies reported the effects on sepsis prevention and mortality improvement. Patients with chronic kidney disease (CKD) are at high risk for CVD and infectious diseases. Limited information is available for statin use in patients with non-dialysis CKD stage V.Method: The retrospective observational study included patients with non-dialysis CKD stage V, with either de novo statin use or none. Patients who were prior statin users and had prior cardiovascular events were excluded. The key outcomes were infection-related hospitalization, major adverse cardiovascular events (MACE) (non-fatal myocardial infarction, hospitalization for heart failure, or non-fatal stroke), and all-cause mortality. The data were retrieved from the Chang Gung Research Database (CGRD) from January 2001 to December 2019. Analyses were conducted with Cox proportional hazard regression models in the propensity score matching (PSM) cohort.Result: A total of 20,352 patients with CKD stage V were included (1,431 patients were defined as de novo statin users). After PSM, 1,318 statin users were compared with 1,318 statin non-users. The infection-related hospitalization (IRH) rate was 79.3 versus 94.3 per 1,000 person-years in statin users and statin non-users, respectively [hazard ratio (HR) 0.83, 95% confidence interval (CI) 0.74–0.93, p = 0.002]. The incidence of MACE was 38.9 versus 55.9 per 1,000 person-years in statin users and non-users, respectively (HR, 0.72; 95% CI 0.62–0.83, p &lt; 0.001). The all-cause mortality did not differ between statin users and non-users, but statin users had lower infection-related mortality than non-users (HR, 0.59; 95% CI 0.38–0.92, p = 0.019).Conclusion:De novo use of statin in patients with non-dialysis CKD stage V reduced the incidence of cardiovascular events, hospitalization, and mortality for infectious disease. The study results reinforced the benefits of statin in a wide range of patients with renal impairment before maintenance dialysis.
Antihypertensive potential of Brassica rapa leaves: An in vitro and in silico approach
Authors: Abid Rohma , Islam Muhammad , Saeed Hamid , Ahmad Abrar , Imtiaz Fariha , Yasmeen Anam , Rathore Hassaan Anwer 
Published: September 2022

Aim:Plants contain many essential constituents and their optimization can result in the discovery of new medicines. One such plant isBrassica rapathat is commonly used as a vegetable to fulfill daily food requirements worldwide. This study intends to screen the phytochemicals, antihypertensive potential, GC-MS, andin silicoanalysis of the leaves ofBrassica rapa.Methods:Powdered leaves were subjected to proximate analysis followed by estimation of primary metabolites. Extracts were obtained by hot and cold extraction and investigated for secondary metabolites. All crude extracts were screened for their antihypertensive potential using an angiotensin-converting enzyme (ACE) inhibition assay. GC-MS analysis was carried out to standardize the extract, and an antihypertensive metabolite was confirmed using anin silicoapproach.Results:Physicochemical evaluation resulted in moisture content (9.10% ± 0.1), total ash value (18.10% ± 0.6), and extractive values (water 9.46% ± 0.5 and alcohol soluble 4.99% ± 0.1), while phytochemical investigation revealed primary metabolites (total proteins 11.90 mg/g ± 0.9; total fats 3.48 mg/g ± 0.5; and total carbohydrates 57.45 mg/g ± 1.2). Methanol extract showed the highest number of secondary metabolites including polyphenols 93.63 mg/g ± 0.6; flavonoids 259.13 mg/g ± 0.6; and polysaccharides 56.63 mg/g ± 1.4, while water extract (70 mg/g ± 2) was rich in glycosaponins. Methanol extract showed the highest antihypertensive potential by inhibiting ACE (79.39%) amongst all extracts, compared to the standard drug captopril, which inhibited 85.81%. Standardization of methanol extractviaGC-MS analysis revealed potent phytoconstituents, and a molecular docking study confirmed that oleic acid is the main antihypertensive metabolite.Conclusion:We conclude that leaves ofBrassica rapacan successfully lower hypertension by inhibiting ACE, however;in vivoinvestigations are required to confirm this antihypertensive activity.
Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways
Authors: Meng Tianwei , Li Xinghua , Li Chengjia , Liu Jiawen , Chang Hong , Jiang Nan , Li Jiarui , Zhou Yabin , Liu Zhiping 
Published: September 2022

Atherosclerosis (AS) is a prevalent arteriosclerotic vascular disease that forms a pathological basis for coronary heart disease, stroke, and other diseases. Inflammatory and oxidative stress responses occur throughout the development of AS. Treatment for AS over the past few decades has focused on administering high-intensity statins to reduce blood lipid levels, but these inevitably damage liver and kidney function over the long term. Natural medicines are widely used to prevent and treat AS in China because of their wide range of beneficial effects, low toxicity, and minimal side effects. We searched for relevant literature over the past 5 years in databases such as PubMed using the keywords, “atherosclerosis,” “traditional Chinese medicine,” “natural medicines,” “inflammation,” and “oxidative stress.” We found that the PI3K/AKT, TLR4, JAK/STAT, Nrf2, MAPK, and NF-κB are the most relevant inflammatory and oxidative stress pathways in AS. This review summarizes studies of the natural alkaloid, flavonoid, polyphenol, saponin, and quinone pathways through which natural medicines used to treat AS. This study aimed to update and summarize progress in understanding how natural medicines treat AS via inflammatory and oxidative stress-related signaling pathways. We also planned to create an information base for the development of novel drugs for future AS treatment.
A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
Authors: Guan Renguo , Yu Chengyou , Li Shaohua , Mei Jie , Wei Wei , Guo Rongping 
Published: September 2022

Background: Combination treatment with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) has been widely used in patients with unresectable hepatocellular carcinoma (uHCC). As no standard guidelines exist for second-line therapy after failure of combination treatment, this study aimed to determine a better drug-switching strategy.Methods: A total of 785 patients with uHCC who initially received a combination treatment of TKIs and ICIs between January 2017 and December 2021 at our center were screened. After applying the inclusion and exclusion criteria, a total of 102 patients were included in the study. Based on drug switching strategy, patients were divided into a single drug-switching group (A group, n = 49) and a double drug-switching group (B group, n = 53). The comparative effectiveness between groups A and B was assessed based on treatment response and survival time. Second progression-free survival (SPFS) and overall survival (OS) were compared using the Kaplan-Meier method and log-rank test.Results: Compared to group B, group A had a higher overall response rate (16.3% vs. 3.8%; p = 0.0392) and disease control rate (61.2% vs. 49.1%; p = 0.238). The median SPFS in group A was longer than that in group B (5.47 vs. 3.8 months; HR = 1.70, p = 0.0176). In the second-line therapy, the inclusion of lenvatinib resulted in a better SPFS than other TKI treatments (5.53 vs. 2.83 months, p = 0.0038).Conclusion: After the failure of the combination treatment of TKIs and ICIs, single-drug switching significantly prolonged median SPFS in uHCC patients, and retaining lenvatinib resulted in the survival benefit of single-drug switching.
Light intensity correction for quartz-enhanced photoacoustic spectroscopy using photothermal baseline
Authors: Chen Xiang , Hu Mai , Liu Hao , Yao Lu , Xu Zhenyu , Kan Ruifeng 
Published: September 2022

A convenient method of light intensity correction for quartz-enhanced photoacoustic spectroscopy (QEPAS) using photothermal baseline is demonstrated. The laser beam passes through the prongs of the quartz tuning fork (QTF) and then focused on the root of the prongs. First harmonic (1f) analysis is utilized to process the simultaneously induced photoacoustic and photothermal signals. The optical path length for photothermal spectroscopy is minimized to millimeter level, yielding negligible gas absorption. The demodulated 1f signal can be regarded as the superposition of the photoacoustic signal and the non-absorption photothermal baseline. A good linear relationship (R2 = 0.999) is observed between amplitude of photothermal baseline and light intensity. QEPAS signal normalized by photothermal baseline shows a good immunity to light intensity variation. An excellent linear response between normalized QEPAS signal and gas concentration is achieved. According to the Allan deviation analysis, the minimum detection limit for CH4 is 0.31 ppm at an integration time of 1,200 s. With this strategy, the precise gas concentration and accurate light intensity of a QEPAS system can be simultaneously obtained with only a single QTF. Compared with the light intensity correction using a photodetector or a power meter, this method entails a low cost and small footprint. It is promising to mitigate the influence from light intensity drift in long-term field measurement of QEPAS systems.
Acute effects of one-leg standing on arterial stiffness in older women: Role of the vision condition and standing dose
Authors: Zhou Zhixiong , Tao Xiaoli , Zhang Yuqin , Zhu Weili 
Published: September 2022

Objective: One-leg standing has been used exclusively for static balance testing and training purposes. We investigated the acute effects of one-leg standing with open or closed eyes on arterial stiffness in older women and explored the role of standing dose in arterial stiffness regulation.Methods: Eighteen older women (60 ± 2 years) underwent non-intervention control (CON), one-leg standing with open eyes for 2 × 3 min (SO2), and one-leg standing with closed eyes for 1 × 3 min (SC1), 2 × 3 min (SC2), and 3 × 3 min trials (SC3) in a randomized self-controlled crossover fashion. Arterial stiffness in the cardio-ankle vascular index (CAVI) was measured at baseline (BL), immediately (0 min), and 10 and 20 min after standing. CAVI changes from BL in the same trial (⊿CAVI) were used for analysis.Results: ⊿CAVI of the non-standing and standing side did not change with time in CON and SO2 trials. In SC1, SC2, and SC3 trials, ⊿CAVI of the standing side decreased significantly at 0 min compared to their corresponding BL (p &lt; 0.01) and reverted gradually to the BL level afterward, with ⊿CAVI of the non-standing side undergoing no changes. At the time point of 0 min, only in the SC2 trial, ⊿CAVI of the standing side was significantly lower than that of CON (p &lt; 0.01).Conclusion: One-leg standing with closed eyes, but not with open eyes, resulted in transient arterial stiffness improvement in older women. The improvement was restricted to standing leg, and the moderate standing dose had maximal benefit on arterial stiffness.
Continuous lighting can improve yield and reduce energy costs while increasing or maintaining nutritional contents of microgreens
Authors: Lanoue Jason , St. Louis Sarah , Little Celeste , Hao Xiuming 
Published: September 2022

Microgreens represent a fast growing segment of the edible greens industry. They are prized for their colour, texture, and flavour. Compared to their mature counterparts, microgreens have much higher antioxidant and nutrient content categorizing them as a functional food. However, current production practices in plant factories with artificial light are energy intensive. Specifically, the lack of sunlight within the indoor structure means all of the light must be provided via energy consuming light fixtures, which is energy intensive and costly. Plant growth is usually increased with the total amount of light provided to the plants - daily light integral (DLI). Long photoperiods of low intensity lighting (greater than 18h) providing the desired/target DLI can reduce the capital costs for light fixtures and electricity costs. This is achieved by moving the electricity use from peak daytime hours (high price) to off-peak hours (low price) during the night in regions with time-based pricing scheme and lowering the electricity use for air conditioning, if plant growth is not compromised. However, lighting with photoperiods longer than tolerance thresholds (species/cultivar specific) usually leads to plant stress/damage. Therefore, we investigated the effects of continuous 24h white light (CL) at two DLIs (~14 and 21 mol m-2 d-1) on plant growth, yield, and antioxidant content on 4 types of microgreens - amaranth, collard greens, green basil, and purple basil to see if it compromises microgreen production. It was found that amaranth and green basil had larger fresh biomass when grown under CL compared to 16h when the DLIs were the same. In addition, purple basil had higher biomass at higher DLI, but was unaffected by photoperiods. Plants grown under the CL treatments had higher energy-use-efficiencies for lighting (10-42%) than plants grown under the 16h photoperiods at the same DLI. Notably, the electricity cost per unit of fresh biomass ($ g-1) was reduced (8-38%) in all microgreens studied when plants were grown under CL lighting at the same DLIs. Amaranth and collard greens also had higher antioxidant content. Taken together, growing microgreens under CL can reduce electricity costs and increase yield while maintaining or improving nutritional content.
Risk factors for postoperative delirium following total hip or knee arthroplasty: A meta-analysis
Authors: Zhao Jinlong , Liang Guihong , Hong Kunhao , Pan Jianke , Luo Minghui , Liu Jun , Huang Bin 
Published: September 2022

ObjectivesThe purpose of this study was to identify risk factors for delirium after total joint arthroplasty (TJA) and provide theoretical guidance for reducing the incidence of delirium after TJA.MethodsThe protocol for this meta-analysis is registered with PROSPERO (CRD42020170031). We searched PubMed, the Cochrane Library and Embase for observational studies on risk factors for delirium after TJA. Review Manager 5.3 was used to calculate the relative risk (RR) or standard mean difference (SMD) of potential risk factors related to TJA. STATA 14.0 was used for quantitative publication bias evaluation.ResultsIn total, 25 studies including 3,767,761 patients from 9 countries were included. Old age has been widely recognized as a risk factor for delirium. Our results showed that the main risk factors for delirium after TJA were patient factors (alcohol abuse: RR = 1.63; length of education: SMD = −0.93; and MMSE score: SMD = −0.39), comorbidities (hypertension: RR = 1.26; diabetes mellitus: RR = 1.67; myocardial infarction: RR = 17.75; congestive heart failure: RR = 2.54; dementia: RR = 17.75; renal disease: RR = 2.98; history of stroke: RR = 4.83; and history of mental illness: RR = 2.36), surgical factors (transfusion: RR = 1.53; general anesthesia: RR = 1.10; pre-operative albumin: SMD = −0.38; pre-operative hemoglobin: SMD = −0.29; post-operative hemoglobin: SMD = −0.24; total blood loss: SMD = 0.15; duration of surgery: SMD = 0.29; and duration of hospitalization: SMD = 2.00) and drug factors (benzodiazepine use: RR = 2.14; ACEI use: RR = 1.52; and beta-blocker use: RR = 1.62).ConclusionsMultiple risk factors were associated with delirium after TJA. These results may help doctors predict the occurrence of delirium after surgery and determine the correct treatment.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier: CRD42020170031.
A prospective study on the association between social support perceived by parents of children aged 1–7 years and the use of community youth health care services
Authors: Fierloos Irene N. , Windhorst Dafna A. , Fang Yuan , Bannink Rienke , Stam Marlinda , Slijkerman Conny A. A. , Jansen Wilma , Raat Hein 
Published: September 2022

AimThis study examined the association between social support perceived by parents of children aged 1–7 years and the use of additional community youth health care services.MethodsData of 749 parents of children aged 1–7 years, gathered in the CIKEO cohort study in the Netherlands, were analyzed. Social support was assessed with the Multidimensional Scale of Perceived Social Support. Data on the use of additional community youth health care services during a period of 1.5 years were obtained from the electronic records of participating youth health care organizations. Multivariable logistic regression models were used to examine the association between perceived social support and the use of additional youth health care services and to explore moderation by the parent's educational level.ResultsThe mean age of the responding parents was 33.9 years (SD = 5.1); 93.6% were mothers. Parents who perceived low to moderate levels of social support had 1.72 (95% CI: 1.11, 2.66) times higher odds of using one or more additional youth health care services during the study period compared to parents who perceived high levels of social support at baseline. This association was independent of predisposing factors, but not independent of need factors (p &gt; 0.05). Furthermore, the association was moderated by the educational level of the parent (p = 0.015). Among parents with a high educational level, low to moderate levels of perceived social support at baseline were associated with 2.93 (95% CI: 1.47, 5.83) times higher odds of using one or more additional youth health care services during the study period independent of predisposing and need factors. Among parents with a low or middle educational level the association between perceived social support and use of additional youth health care services was not significant.ConclusionOur findings provide evidence that low to moderate levels of perceived social support are associated with a higher use of additional community youth health care services among parents of children aged 1–7 years, especially among high educated parents. Recommendations for policy and practice are provided.